Last update Jan. 13, 2023
It is a first generation anti-histaminic and piperazine drug with a moderate sedative effect. Commercialized in association with other drugs for coughing relief and expectorant compounds. It has been used to treat hives, rhinitis, pruritus, and other allergy symptoms, and as an antiemetic. Oral administration.
At the date of the last update we did not find any published data on its excretion in breast milk.
Its high binding to plasma proteins makes it difficult to pass into breast milk.
Avoid drug associations, in general, and more during lactation.
The literature on this drug is scarce and it is sold in few countries.
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM